1. Home
  2. BLZE vs MDWD Comparison

BLZE vs MDWD Comparison

Compare BLZE & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Backblaze Inc.

BLZE

Backblaze Inc.

HOLD

Current Price

$4.12

Market Cap

277.4M

Sector

Technology

ML Signal

HOLD

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$17.81

Market Cap

224.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLZE
MDWD
Founded
2007
2000
Country
United States
Israel
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
277.4M
224.6M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
BLZE
MDWD
Price
$4.12
$17.81
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
2
Target Price
$9.50
$37.50
AVG Volume (30 Days)
634.6K
135.7K
Earning Date
02-23-2026
03-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$141,859,000.00
$20,932,000.00
Revenue This Year
$16.40
$6.97
Revenue Next Year
$10.46
$23.59
P/E Ratio
N/A
N/A
Revenue Growth
15.73
6.15
52 Week Low
$3.94
$14.14
52 Week High
$10.86
$22.51

Technical Indicators

Market Signals
Indicator
BLZE
MDWD
Relative Strength Index (RSI) 30.00 46.81
Support Level $3.95 $17.10
Resistance Level $4.75 $18.48
Average True Range (ATR) 0.22 0.72
MACD -0.07 0.01
Stochastic Oscillator 12.35 52.43

Price Performance

Historical Comparison
BLZE
MDWD

About BLZE Backblaze Inc.

Backblaze Inc provides cloud storage services. The company offers services such as Backblaze B2 Cloud Storage, which enables customers to store data, developers to build applications, and partners to expand their use cases. It is offered as a consumption-based Infrastructure-as-a-Service (IaaS) and serves use cases including backups, multi-cloud, application development, and ransomware protection and Backblaze Computer Backup automatically backs up data from laptops and desktops for businesses and individuals. Geographically, it derives a majority of revenue from the United States and the rest from the United Kingdom, Canada, and Other regions.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: